Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|May 2, 2023
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020Morgan A Alford, James A Karlowsky, Heather J Adam, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23)Anissa Brahami, James A Karlowsky, Melissa McCracken, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2015
Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13Alyssa R Golden, Heather J Adam, Matthew W Gilmour, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23)Laura F Mataseje, Nicole Lerminiaux, Philippe Lagacé-Wiens, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2015
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13Alyssa R Golden, Margot Rosenthal, Ben Fultz, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16Alyssa R Golden, Melanie R Baxter, Ross J Davidson, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2018
In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coliJames A Karlowsky, Heather J Adam, Melanie R Baxter, et al.
Microbiology Spectrum|June 27, 2022
In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019James A Karlowsky, Andrew J Walkty, Melanie R Baxter, et al.
Pageof 10